Newsletter | 01 July 2004 Access News 10, Focus on AIDS Treatment, July 2004 INTELLECTUAL PROPERTY AND TRADE In this edition of AccessNews, the challenges of AIDS treatment is focused on, as well as the importance of patient activism to expand treatment, MSF AIDS programs FDCs and Africa starting to ACT against malaria. Read, watch, share Filter by - Any -BlogEventsFeature storyInterviewIssue briefLetterNewsletterOpinion articlePhoto storyPress releaseReportReport seriesResearch articleSpeechStatementTechnical briefVideo Photo credit: Njiiri Karago/MSF Press release Press release | 17 August 2023 HIV/AIDS MSF refuses to sign ViiV’s last-minute NDA for access to most-effective HIV prevention drug CAB-LA 4 min Letter Letter | 13 July 2023 HIV/AIDS Intellectual property and trade Colombia CSO letter supporting Resolution 881/23 by Colombia on issuing a compulsory license for HIV drug dolutegravir Photo credit: Paul Odongo/MSF Press release Press release | 11 May 2023 Diagnostics HIV/AIDS Access to point-of-care tests for people with advanced HIV under threat as diagnostics corporations to stop production 3 min Photograph by Valerie Baeriswyl Press release Press release | 30 March 2023 HIV/AIDS Pharmaceutical corporation ViiV must improve its failing access strategy for lifesaving HIV prevention drug 5 min Technical brief | 02 February 2023 HIV/AIDS Agents of Change: Long-acting Formulations for Prevention and Treatment of HIV Photograph by Albert Masias Press release Press release | 29 November 2022 HIV/AIDS Pharmaceutical corporation ViiV must make ground-breaking HIV prevention injection affordable and available 5 min Technical brief | 13 September 2022 Diagnostics Africa-South Korea Roundtable: Working Together on Local Production of Diagnostics Statement | 23 August 2022 Diagnostics Principles for Access to Multi-disease Molecular Diagnostics Load More
Photo credit: Njiiri Karago/MSF Press release Press release | 17 August 2023 HIV/AIDS MSF refuses to sign ViiV’s last-minute NDA for access to most-effective HIV prevention drug CAB-LA 4 min
Letter Letter | 13 July 2023 HIV/AIDS Intellectual property and trade Colombia CSO letter supporting Resolution 881/23 by Colombia on issuing a compulsory license for HIV drug dolutegravir
Photo credit: Paul Odongo/MSF Press release Press release | 11 May 2023 Diagnostics HIV/AIDS Access to point-of-care tests for people with advanced HIV under threat as diagnostics corporations to stop production 3 min
Photograph by Valerie Baeriswyl Press release Press release | 30 March 2023 HIV/AIDS Pharmaceutical corporation ViiV must improve its failing access strategy for lifesaving HIV prevention drug 5 min
Technical brief | 02 February 2023 HIV/AIDS Agents of Change: Long-acting Formulations for Prevention and Treatment of HIV
Photograph by Albert Masias Press release Press release | 29 November 2022 HIV/AIDS Pharmaceutical corporation ViiV must make ground-breaking HIV prevention injection affordable and available 5 min
Technical brief | 13 September 2022 Diagnostics Africa-South Korea Roundtable: Working Together on Local Production of Diagnostics
